Citigroup
HURA

Citigroup’s TuHURA Biosciences HURA Stock Holding History

Citigroup’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.47K Buy
1,937
+1,185
+158% +$1.45K ﹤0.01% 5339
2025
Q4 		$569 Sell
752
-929
-55% -$1.78K ﹤0.01% 5579
2025
Q3 		$4.17K Sell
1,681
-7,438
-82% -$19.6K ﹤0.01% 5281
2025
Q2 		$20.3K Buy
+9,119
New +$30.8K ﹤0.01% 5074
2025
Q1 		– Sell
-65,013
Closed -$266K – 6055
2024
Q4 		$266K Buy
+65,013
New +$346K ﹤0.01% 4236
2022
Q2 		– Hold
0
– – – 6746
2022
Q1 		– Hold
0
– – – 6658

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Citigroup's HURA Position: Q1 2026 in Review

Citigroup increased its TuHURA Biosciences (HURA) stake by 158% in Q1 2026, buying an estimated $1.45K and bringing the position to 1,937 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #5339.

Citigroup first reported a position in HURA in Q4 2024 and has held it in 5 quarters since. The position peaked at $266K in Q4 2024. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Citigroup held 1,937 shares of TuHURA Biosciences worth $3.47K as of Q1 2026.
  • Citigroup bought 1,185 TuHURA Biosciences shares in Q1 2026, an estimated $1.45K.
  • TuHURA Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5339 holding.
  • Citigroup first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 5 quarters since.
  • Citigroup's TuHURA Biosciences position peaked at $266K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.